Published in Hum Mutat on November 01, 2006
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91
A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res (2010) 1.68
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? Breast Cancer Res (2008) 1.44
Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res (2011) 1.36
Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res (2010) 1.26
Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk. Hum Mutat (2009) 1.18
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol (2008) 1.13
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res (2013) 1.09
The spectrum of ATM missense variants and their contribution to contralateral breast cancer. Breast Cancer Res Treat (2007) 1.03
Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res (2008) 1.00
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. Leuk Lymphoma (2012) 0.96
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet (2016) 0.95
Not All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation Detection. Cancers (Basel) (2015) 0.94
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev (2010) 0.91
Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol (2016) 0.87
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia. Br J Cancer (2011) 0.87
Variants in the ATM gene and breast cancer susceptibility. Genome Med (2009) 0.86
Tumour morphology predicts PALB2 germline mutation status. Br J Cancer (2013) 0.85
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast Cancer Res (2011) 0.79
Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry. Breast Cancer Res (2012) 0.79
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet (2016) 0.79
A Bayesian Hierarchical Model for Relating Multiple SNPs within Multiple Genes to Disease Risk. Int J Genomics (2013) 0.75
The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia. J Biol Chem (2016) 0.75
ATM mutations for surgeons. Fam Cancer (2016) 0.75
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Reproductive factors and breast cancer. Epidemiol Rev (1993) 8.37
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell (1996) 7.86
Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet (1982) 7.07
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol (1988) 4.97
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell (1998) 4.72
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. J Natl Cancer Inst (2009) 4.24
Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev (1988) 4.23
Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda. Microbiol Rev (1984) 4.17
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13
Asthma and air pollution in the Los Angeles area. Am J Public Health (1980) 4.02
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet (1999) 3.95
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature (1988) 3.82
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst (1995) 3.67
ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet (2000) 3.49
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev (1999) 3.29
Complete separation of lipid classes on a single thin-layer plate. J Lipid Res (1966) 3.29
Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust (1993) 3.28
A prospective population-based study of menopausal symptoms. Obstet Gynecol (2000) 3.27
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
The geographic distribution of human Y chromosome variation. Genetics (1997) 3.18
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res (1999) 3.11
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 3.03
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer (1993) 2.99
Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol (1996) 2.91
Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc Natl Acad Sci U S A (1998) 2.81
Methods for analyzing panel studies of acute health effects of air pollution. Biometrics (1979) 2.76
DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell (2001) 2.69
Identification of elements involved in transcriptional regulation of the Escherichia coli cad operon by external pH. J Bacteriol (1992) 2.61
Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med (1993) 2.61
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc Natl Acad Sci U S A (1997) 2.52
Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res (1997) 2.45
Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet (2000) 2.43
Sexual factors and prostate cancer. BJU Int (2003) 2.38
Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut (2005) 2.37
The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer (1998) 2.34
Computer dosing in anticoagulant clinics--the way forward? Clin Lab Haematol (1988) 2.28
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet (1999) 2.26
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Diversity and structure of human T-cell receptor beta-chain variable region genes. Proc Natl Acad Sci U S A (1986) 2.19
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut (2011) 2.14
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
Regulated genomic instability and neoplasia in the lymphoid lineage. Blood (1999) 2.13
Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis (1990) 2.12
Pregnancy outcome at age 40 and older. Obstet Gynecol (1996) 2.09
Breast cancer in Australian women under the age of 40. Cancer Causes Control (1998) 2.08
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet (1995) 2.07
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res (1998) 2.07
Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet (1994) 2.06
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol (1995) 2.04
Isolation and characterization of Caulobacter crecentus bacteriophage phi Cd1. J Virol (1976) 2.00
Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust (2000) 2.00
Factors in childhood as predictors of asthma in adult life. BMJ (1994) 2.00
Hypertonic saline solution for wound dressing. Lancet (1992) 2.00
Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol (1998) 2.00
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer (2010) 1.99
Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. Am J Hum Genet (1991) 1.98
Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev (2000) 1.96
Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr (1999) 1.95
Differences in socioeconomic status and survival among white and black men with prostate cancer. Am J Epidemiol (2000) 1.95
Epileptic seizures in acute stroke. Arch Neurol (1990) 1.94
Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust (1994) 1.92
Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology (1995) 1.91
Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol (1998) 1.91
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Respiratory symptoms in Tasmanian adolescents: a follow up of the 1961 birth cohort. Aust N Z J Med (1984) 1.88
Risk factors for severe preeclampsia. Obstet Gynecol (1994) 1.87
Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine. J Bacteriol (1996) 1.85
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer (1999) 1.83
Global analysis of proteins synthesized during phosphorus restriction in Escherichia coli. J Bacteriol (1996) 1.81
Cost of care for cancer in a health maintenance organization. Health Care Financ Rev (1997) 1.81
Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet (2000) 1.80
Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem (1987) 1.75